These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2959900)

  • 41. Bronchodilating and density dependence effects of fenoterol, ipratropium bromide and Duovent in reversible chronic obstructive pulmonary disease.
    Dubois PE; Delwiche JP; Minette P; Lulling J; Prignot J
    Respiration; 1986; 50 Suppl 2():280-4. PubMed ID: 2951822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [What dosage is sufficient in combined inhalation therapy (fenoterol + ipratropium bromide) in patients with exacerbation of chronic obstructive lung disease?].
    Musil J; Hirsch V; Vondra V; Reisová M
    Vnitr Lek; 1998 Jul; 44(7):415-7. PubMed ID: 9748878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ipratropium bromide and fenoterol by aerosolized solution.
    Jenkins CR; Chow CM; Fisher BL; Marlin GE
    Br J Clin Pharmacol; 1982 Jul; 14(1):113-5. PubMed ID: 6213250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of the effects of anticholinergic and beta 2-agonist and combination therapy on respiratory impedance in COPD.
    Wesseling G; Mostert R; Wouters EF
    Chest; 1992 Jan; 101(1):166-73. PubMed ID: 1530836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Respimat (a new soft mist inhaler) delivering fenoterol plus ipratropium bromide provides equivalent bronchodilation at half the cumulative dose compared with a conventional metered dose inhaler in asthmatic patients.
    Kunkel G; Magnussen H; Bergmann K; Juergens UR; de Mey C; Freund E; Hinzmann R; Beckers B
    Respiration; 2000; 67(3):306-14. PubMed ID: 10867600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Nebulization in acute asthma. Association of an atropine and a beta2-sympathomimetic].
    Dusser D
    Ann Fr Anesth Reanim; 1998; 17 Suppl 2():40s-43s. PubMed ID: 9881207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Nebuliser delivery of berodual in patients with bronchial asthma and chronic obstructive bronchitis].
    Iakushin SS; Smirnova EA
    Klin Med (Mosk); 1999; 77(7):49. PubMed ID: 10483167
    [No Abstract]   [Full Text] [Related]  

  • 48. [Bronchodilator treatment of COPD].
    Naberan K
    Aten Primaria; 1998 Feb; 21(2):109-13. PubMed ID: 9608136
    [No Abstract]   [Full Text] [Related]  

  • 49. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
    Gross NJ; Petty TL; Friedman M; Skorodin MS; Silvers GW; Donohue JF
    Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department.
    Browne GJ; Trieu L; Van Asperen P
    Crit Care Med; 2002 Feb; 30(2):448-53. PubMed ID: 11889328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nebulized fenoterol and i.v. aminophylline in acute severe asthma.
    Bowler SD; Mitchell CA; Armstrong JG; Scicchitano R
    Eur J Respir Dis; 1987 May; 70(5):280-3. PubMed ID: 3609188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Basic medication of chronic obstructive lung disease with berodual].
    Melent'eva EM
    Klin Med (Mosk); 1999; 77(7):47-8. PubMed ID: 10483166
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of the bronchodilator efficacy of nebulized pirenzepine and ipratropium bromide in patients with airway obstructive lung disease.
    Ceyhan B; Celikel T; Simsir S; Kandemir B
    Int J Clin Pharmacol Ther Toxicol; 1993 Oct; 31(10):510-3. PubMed ID: 8262690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparison of bronchodilator effects and site of action of fenoterol and ipratropium in chronic obstructive bronchitis].
    Kheir A; Ying Y; Hannhart B; Duvivier C; Peslin R; Polu JM
    Rev Mal Respir; 1993; 10(1):9-15. PubMed ID: 8451502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A prospective, comparative trial of standard and breath-actuated nebulizer: efficacy, safety, and satisfaction.
    Arunthari V; Bruinsma RS; Lee AS; Johnson MM
    Respir Care; 2012 Aug; 57(8):1242-7. PubMed ID: 22348319
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nebulized hypertonic saline solution for acute bronchiolitis in infants.
    Zhang L; Mendoza-Sassi RA; Wainwright C; Klassen TP
    Cochrane Database Syst Rev; 2008 Oct; (4):CD006458. PubMed ID: 18843717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of lung function and postnatal age on the response to nebulized ipratropium bromide in children born prematurely.
    Yüksel B; Greenough A
    Respir Med; 1994 Aug; 88(7):527-30. PubMed ID: 7972978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute controlled study of the dose-response relationship of fenoterol, ipratropium bromide and their combination.
    Serra C; Giacopelli A; Luciani G
    Respiration; 1986; 50 Suppl 2():144-7. PubMed ID: 2951793
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of short-acting bronchodilators added to maintenance tiotropium therapy.
    Kerstjens HA; Bantje TA; Luursema PB; Sinninghe Damste HE; de Jong JW; Lee A; Wijker SP; Cornelissen PJ
    Chest; 2007 Nov; 132(5):1493-9. PubMed ID: 17890476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
    Maesen FP; Greefhorst LP; Smeets JJ; Wald FD; Cornelissen PJ
    Respiration; 1997; 64(4):273-80. PubMed ID: 9257362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.